---
figid: PMC5891174__CAS-109-893-g003
figtitle: Crosstalk of DNA double‐strand break repair pathways in poly(ADP‐ribose)
  polymerase inhibitor treatment of breast cancer susceptibility gene 1/2‐mutated
  cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC5891174
filename: CAS-109-893-g003.jpg
figlink: /pmc/articles/PMC5891174/figure/cas13530-fig-0003/
number: F3
caption: Loss of p53‐binding protein 1 (53BP1)‐induced resistance mechanism to poly(ADP‐ribose)
  polymerase (PARP) inhibitor in breast cancer susceptibility gene 1 (BRCA1)‐ and
  breast cancer susceptibility gene 2 (BRCA2)‐deficient cells through double‐strand
  break (DSB) repair and ensuing pathways during the S/G2 cell cycle phase were compared.
  Pathway differences in PARP inhibitor sensitivity with additional loss of 53BP1
  were analyzed in (A) BRCA1‐deficient and (B) BRCA2‐deficient cells. CDK, cyclin‐dependent
  kinase; CtIP, C‐terminal‐binding protein interacting protein; DNA‐PKcs, DNA‐dependent
  protein kinase catalytic subunit; HR, homologous recombination; Lig4, DNA ligase
  IV; NHEJ, non‐homologous end joining; RIF1, Rap1‐interacting factor 1
papertitle: Crosstalk of DNA double‐strand break repair pathways in poly(ADP‐ribose)
  polymerase inhibitor treatment of breast cancer susceptibility gene 1/2‐mutated
  cancer.
reftext: Shigeaki Sunada, et al. Cancer Sci. 2018 Apr;109(4):893-899.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9514443
figid_alias: PMC5891174__F3
figtype: Figure
redirect_from: /figures/PMC5891174__F3
ndex: 4135218f-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5891174__CAS-109-893-g003.html
  '@type': Dataset
  description: Loss of p53‐binding protein 1 (53BP1)‐induced resistance mechanism
    to poly(ADP‐ribose) polymerase (PARP) inhibitor in breast cancer susceptibility
    gene 1 (BRCA1)‐ and breast cancer susceptibility gene 2 (BRCA2)‐deficient cells
    through double‐strand break (DSB) repair and ensuing pathways during the S/G2
    cell cycle phase were compared. Pathway differences in PARP inhibitor sensitivity
    with additional loss of 53BP1 were analyzed in (A) BRCA1‐deficient and (B) BRCA2‐deficient
    cells. CDK, cyclin‐dependent kinase; CtIP, C‐terminal‐binding protein interacting
    protein; DNA‐PKcs, DNA‐dependent protein kinase catalytic subunit; HR, homologous
    recombination; Lig4, DNA ligase IV; NHEJ, non‐homologous end joining; RIF1, Rap1‐interacting
    factor 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - TP53BP1
  - BRCA1
  - RBBP8
  - RIF1
  - INSL6
  - LRIF1
  - LIG4
  - RAD51
  - BRCA2
  - Trp53bp1
  - Brca1
  - Rbbp8
  - Rif1
  - Insl6
  - Lig4
  - Rad51
  - Xrcc2
  - Brca2
  - rif1
  - lig4
  - rad51
  - brca2
---
